1. Immunology/Inflammation Apoptosis
  2. SphK Apoptosis
  3. SKI-I

SKI-I is a potent and selective inhibitor of human sphingosine kinase (SK), with an IC50 of 1.2 μM for ST-hSK. SKI-I also inhibits hERK2 (IC50=11 μM). SKI-I induces apoptosis in tumor cell lines.

For research use only. We do not sell to patients.

SKI-I Chemical Structure

SKI-I Chemical Structure

CAS No. : 306301-68-8

Size Price Stock Quantity
Free Sample (0.1 - 0.5 mg)   Apply Now  
5 mg USD 240 In-stock
10 mg USD 380 In-stock
25 mg USD 720 In-stock
50 mg USD 1150 In-stock
100 mg USD 1850 In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products

View All SphK Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

SKI-I is a potent and selective inhibitor of human sphingosine kinase (SK), with an IC50 of 1.2 μM for ST-hSK. SKI-I also inhibits hERK2 (IC50=11 μM). SKI-I induces apoptosis in tumor cell lines[1][2].

IC50 & Target

IC50: 1.2 μM (ST-hSK); 11 μM (hERK2)[1]

Cellular Effect
Cell Line Type Value Description References
A549 IC50
3.8 μM
Compound: 4, SKI-I
Cytotoxicity against human A549 cells after 72 hrs by SRB assay
Cytotoxicity against human A549 cells after 72 hrs by SRB assay
[PMID: 20598402]
HeLa IC50
1 μM
Compound: 4, SKI-I
Cytotoxicity against human HeLa cells after 72 hrs by SRB assay
Cytotoxicity against human HeLa cells after 72 hrs by SRB assay
[PMID: 20598402]
MCF-10A IC50
4.1 μM
Compound: 4, SKI-I
Cytotoxicity against human MCF10A cells after 72 hrs by SRB assay
Cytotoxicity against human MCF10A cells after 72 hrs by SRB assay
[PMID: 20598402]
MDA-MB-231 IC50
4.4 μM
Compound: 4, SKI-I
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by SRB assay
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by SRB assay
[PMID: 20598402]
MEF IC50
5 μM
Compound: 4, SKI-I
Cytotoxicity against MEF after 72 hrs by SRB assay
Cytotoxicity against MEF after 72 hrs by SRB assay
[PMID: 20598402]
MIA PaCa-2 IC50
4.8 μM
Compound: 4, SKI-I
Cytotoxicity against human MIAPaCa2 cells after 72 hrs by SRB assay
Cytotoxicity against human MIAPaCa2 cells after 72 hrs by SRB assay
[PMID: 20598402]
NCI-H226 IC50
5.7 μM
Compound: 4, SKI-I
Cytotoxicity against human NCI-H226 cells after 72 hrs by SRB assay
Cytotoxicity against human NCI-H226 cells after 72 hrs by SRB assay
[PMID: 20598402]
NCI-H441 IC50
2 μM
Compound: 4, SKI-I
Cytotoxicity against human H441 cells after 72 hrs by SRB assay
Cytotoxicity against human H441 cells after 72 hrs by SRB assay
[PMID: 20598402]
NCI-H460 IC50
3.2 μM
Compound: 4, SKI-I
Cytotoxicity against human H460 cells after 72 hrs by SRB assay
Cytotoxicity against human H460 cells after 72 hrs by SRB assay
[PMID: 20598402]
U-87MG ATCC IC50
1 μM
Compound: 4, SKI-I
Cytotoxicity against human U87MG cells after 72 hrs by SRB assay
Cytotoxicity against human U87MG cells after 72 hrs by SRB assay
[PMID: 20598402]
In Vitro

SKI-I (Compound I; 5 μg/mL) inhibits SK activity by 99%[1].
SKI-I (10 μM; 24 h) induces the apoptosis of T24 cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molecular Weight

406.44

Formula

C25H18N4O2

CAS No.
Appearance

Solid

Color

Off-white to light yellow

SMILES

O=C(C1=NNC(C2=CC=C3C=CC=CC3=C2)=C1)N/N=C/C4=C5C=CC=CC5=CC=C4O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility
In Vitro: 

DMSO : 100 mg/mL (246.04 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.4604 mL 12.3019 mL 24.6039 mL
5 mM 0.4921 mL 2.4604 mL 4.9208 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    90% Corn Oil

    Solubility: ≥ 2.5 mg/mL (6.15 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.4604 mL 12.3019 mL 24.6039 mL 61.5097 mL
5 mM 0.4921 mL 2.4604 mL 4.9208 mL 12.3019 mL
10 mM 0.2460 mL 1.2302 mL 2.4604 mL 6.1510 mL
15 mM 0.1640 mL 0.8201 mL 1.6403 mL 4.1006 mL
20 mM 0.1230 mL 0.6151 mL 1.2302 mL 3.0755 mL
25 mM 0.0984 mL 0.4921 mL 0.9842 mL 2.4604 mL
30 mM 0.0820 mL 0.4101 mL 0.8201 mL 2.0503 mL
40 mM 0.0615 mL 0.3075 mL 0.6151 mL 1.5377 mL
50 mM 0.0492 mL 0.2460 mL 0.4921 mL 1.2302 mL
60 mM 0.0410 mL 0.2050 mL 0.4101 mL 1.0252 mL
80 mM 0.0308 mL 0.1538 mL 0.3075 mL 0.7689 mL
100 mM 0.0246 mL 0.1230 mL 0.2460 mL 0.6151 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
SKI-I
Cat. No.:
HY-115735
Quantity:
MCE Japan Authorized Agent: